ClinicalTrials.gg
Not yet recruitingNCT07854535Updated Oct 2, 2026

Tibialis Posterior Muscle Morphology in Flexible Flatfeet Subjects

An observational study in Flexible Flatfoot, sponsored by Cairo University. Not yet recruiting at 1 site in Egypt. Open to participants aged 18 Years to 40 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-10-02.

Sponsored by Cairo University · Observational

How we know

Updated Oct 2, 2026Newly registeredGo to Updates ↓

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Study type
Observational
Model
Other
Time perspective
Cross-sectional
Enrollment
45
Ages
18 Years to 40 Years
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 16 studies in Flatfoot with a site in Egypt — 7 open to participants now, 7 under way, none of them phase 3. Flatfoot · Egypt.

Started
2026
with 1 other
Observational
4 of 16
2 open now
Registered
16th of 16
by date
Lead sponsor
5 of 16
Cairo University

Among the 16 studies in Flatfoot with a site in Egypt, this one is one of 2 that started in 2026, is one of 4 observational ones, and was the 16th registered.

Flatfoot

173 studies on the registry are indexed under Flatfoot; 44 are open to participants now.

Browse Flatfoot studies →

Open to participants now

7 of the 16 studies in Flatfoot with a site in Egypt are open now. Recruiting first, the newest first:

1 more — sign in →

All 7 open studies →

A study can be open while its sites in Egypt have not opened yet or have stopped. Only those recruiting at a site in Egypt →

Who these studies take

Of the 24 Flatfoot studies recruiting now, 3 (13%) set no upper age limit and 20 (83%) stop at 75 or younger; 8 take children under 18; 6 take healthy volunteers.

This study: 18 Years to 40 Years · all sexes · healthy volunteers too.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 16 studies in Flatfoot with a site in Egypt, or all of them as a file.
02

Study summary

The goal of this observational study is to assess tibialis posterior muscle morphology in adults with flexible flatfeet. The main question it aims to answer is:

Are there differences in tibialis posterior muscle morphology between adults with symptomatic flexible flatfeet, asymptomatic flexible flatfeet, and individuals with normal foot posture?

Participants will undergo clinical assessment of foot posture and symptoms and an ultrasound assessment of the tibialis posterior muscle. The study will compare muscle thickness, cross-sectional area, and echo intensity among the three groups.

Read the detailed description

Flexible flatfoot involves altered mechanics of the foot and may influence the functional demands placed on the structures responsible for maintaining the medial longitudinal arch. The tibialis posterior muscle is an important dynamic contributor to medial arch support and plays a role in controlling pronation and maintaining foot stability during functional activities.

Although flexible flatfoot has been widely investigated from clinical and biomechanical perspectives, less is known about the morphological characteristics of the tibialis posterior muscle in relation to this condition. In particular, differences associated with the presence or absence of symptoms have not been sufficiently characterized. Evaluating muscle morphology may provide additional information about the muscular adaptations associated with altered foot posture.

The rationale for this study is to investigate whether the morphological characteristics of the tibialis posterior muscle differ across individuals with different clinical presentations of foot posture. Comparing these characteristics may help clarify whether muscular morphological changes are associated with flexible flatfoot itself or with the presence of symptoms.

The study findings may contribute to a better understanding of the muscular component of flexible flatfoot and provide information that may be useful for future research investigating assessment and rehabilitation strategies for individuals with this condition.

03

Conditions studied

  • Flexible Flatfoot

Browse trials for

Keywords

  • Flexible Flatfoot
  • Tibialis Posterior Muscle
  • Muscle Morphology
  • Ultrasound
  • Foot Posture
  • Muscle thickness
  • Muscle Cross sectional Area
04

Who can participate

Ages eligible
18 Years to 40 Years
Sexes eligible
All
Accepts healthy volunteers
Yes
Sampling method
Non-probability sample

Study population

Participants will be recruited from individuals attending the outpatient clinics of the Faculty of Physical Therapy, Cairo University, and New Cairo Hospital. The study population will include individuals presenting with different foot postures, including those with flexible flatfoot and individuals with normal foot posture. Eligible participants who meet the study criteria and provide informed consent will be enrolled in the study.

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Adults aged 18 to 40 years.
  • Both males and females will be eligible to participate.
  • (BMI) ≤30 kg/m².
  • Participants with flexible flatfoot will demonstrate a visible medial longitudinal arch in the non-weight-bearing position and flattening of the arch during full weight-bearing.
  • Participants with flexible flatfoot will have a Foot Posture Index-6 (FPI-6) score of ≥+6.
  • Participants in the normal foot posture control group will have an FPI-6 score ranging from 0 to +5.
  • Participants must be able to stand and walk independently without an assistive device.
  • Participants must be willing to participate in the study and provide .

Exclusion criteria

Exclusion Criteria:

  • History of previous surgery involving the foot, ankle, or lower limb.
  • History of significant trauma or fracture involving the foot, ankle, or lower limb.
  • Presence of rigid flatfoot or other structural foot deformities.
  • Presence of neurological disorders affecting the lower limb.
  • Presence of neuromuscular disorders affecting the lower limb.
  • Presence of systemic or inflammatory musculoskeletal conditions affecting the lower limb.
  • Current lower-limb injury or condition that may affect standing, walking, foot posture, or tibialis posterior muscle morphology.
  • Pregnancy.
  • Participants who are unable to follow the assessment procedures or complete the required study measurements.
Terms in these criteria, in plain language(2)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

BMI (body mass index)

Weight in kilograms divided by height in metres squared. Example: 70 kg and 1.75 m gives 70 ÷ (1.75 × 1.75) ≈ 22.9.

What counts as overweight or obesity differs between countries (some use lower cut-offs), so go by the range the study states.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

05

Study design

Observational model
Other
Time perspective
Cross-sectional
Enrollment
45 participants (estimated)
Patient registry
No

Groups and cohorts

  • Symptomatic Flexible Flatfoot

    Participants with flexible flatfoot who have foot-related symptoms.

    Other: Tibialis Posterior Muscle Morphology Assessment

  • Asymptomatic Flexible Flatfoot

    Participants with flexible flatfoot who do not have foot-related symptoms.

    Other: Tibialis Posterior Muscle Morphology Assessment

  • Normal Foot Posture (Control)

    Participants with normal foot posture who do not meet the study criteria for flexible flatfoot.

    Other: Tibialis Posterior Muscle Morphology Assessment

Interventions

  • OtherTibialis Posterior Muscle Morphology Assessment

    Assessment of tibialis posterior muscle morphology using B-mode diagnostic ultrasound as a non-invasive measurement method. The assessment is performed for research purposes and does not involve administration of treatment or modification of participants' usual care.

06

What researchers measure

Primary outcomes

  1. Tibialis Posterior Muscle Thickness

    Tibialis posterior muscle thickness will be assessed using B-mode diagnostic ultrasonography with a high-frequency linear transducer. The ultrasound measurement site will be standardized at 30% of the shank length according to the predefined study protocol. Minimal transducer pressure will be applied to avoid muscle compression. Multiple images will be obtained, and the mean measurement will be used for statistical analysis.

    Time frame: Baseline assessment during a single study visit.

  2. Tibialis Posterior Muscle Cross-sectional Area

    Tibialis posterior muscle cross-sectional area will be assessed using B-mode diagnostic ultrasonography with a high-frequency linear transducer. The ultrasound measurement site will be standardized at 30% of the shank length according to the predefined study protocol. Minimal transducer pressure will be applied to avoid muscle compression. Multiple images will be obtained, and the mean cross-sectional area measurement will be used for statistical analysis.

    Time frame: Baseline assessment during a single study visit.

Secondary outcomes

  1. Tibialis Posterior Muscle Stiffness

    Tibialis posterior muscle stiffness will be assessed using shear wave elastography (SWE) with an ultrasound system equipped with a high-frequency linear transducer. The ultrasound measurement site will be standardized at 30% of the shank length according to the predefined study protocol. Minimal transducer pressure will be applied to avoid muscle deformation. Multiple measurements will be obtained, and the mean stiffness value will be used for statistical analysis.

    Time frame: Baseline assessment during a single study visit.

  2. Foot Posture Index-6 (FPI-6)

    Foot posture will be assessed using the Foot Posture Index-6 (FPI-6) during relaxed standing. The FPI-6 consists of six observational and palpation-based items used to assess foot posture, with each item scored from -2 to +2. The total score ranges from -12 to +12, with higher scores indicating a more pronated foot posture.

    Time frame: Baseline assessment during a single study visit.

  3. Pain intensity level

    Pain intensity will be assessed using the Arabic version of the Numeric Pain Rating Scale (Arabic NPRS). Participants will rate their foot-related pain on a numerical scale from 0 to 10, where 0 indicates no pain and 10 indicates the worst pain imaginable. The Arabic NPRS will be administered according to its validated Arabic version.

    Time frame: Baseline assessment during a single study visit.

07

Study locations

1 site
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Start is estimated for Oct 2026; primary completion for Feb 2027, 4 months later.

How these figures are worked out, and which studies are left out of them.

Registered
Sep 27, 2026
First posted
Oct 2, 2026
StartEst.
Oct 2026
Primary completionEst.
Feb 2027
CompletionEst.
Mar 2027
Last update
Oct 2, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Registered
First appeared on the registry. No changes since
Oct 2, 2026
Show all 1 update
  1. Oct 2, 2026
    First appeared on the registry

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT07854535
Lead sponsor
Cairo University
Responsible party
Hend Ahmed Mansour (Principal Investigator, Cairo University) — Principal investigator
First posted
Oct 2, 2026
Start date
Oct 2026 (estimated)
Primary completion
Feb 2027 (estimated)
Completion
Mar 2027 (estimated)
Last update
Oct 2, 2026

Study contacts

Hend Ahmed, B.Sc
Contact
hendahmed63@gmail.com
+201113097799
Abdallah Mohamed Kamel, PhD
Contact
Nabil Abdo Abdellah Mohamed, PhD
study chair · Ass. Professor, Cairo University
Hatem Mohamed Said El-Azizi, PhD
study director · Professor, Cairo University
Abdallah Mohamed Kamel, PhD
study director · Lecturer, Cairo University

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Sep 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion